The role and impact of 68Ga-PSMA PET in the initial staging of prostate cancer and its potential implications in radiotherapy planning.

Congress:

2018 ASM

Poster Number:

R-0083

Type:

Scientific Exhibit

Keywords:

Genital / Reproductive system male, Nuclear medicine, PET, PET-CT, CT, Comparative studies, Staging, Radiation therapy / Oncology, Cancer

Authors:

H. Wong, J. Leung, D. Bartholomeusz, P. Sutherland, H. Le, M. Nottage, I. Iankov, J. Chang; SA/AU

DOI:

10.1594/ranzcr2018/R-0083

DOI-Link:

https://dx.doi.org/10.1594/ranzcr2018/R-0083

Conclusion

•The use of 68Ga-PSMA PET scans in initial staging of prostate cancer has a significant impact compared to current recommended imaging modalities.

•The significant change in stage and management justifies its use in at least intermediate and high risk disease.

•Particularly useful when suspicious oligometastatic disease is found on conventional imaging modalities.